65 results
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
12 Mar 24
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
8:15am
in the prior year. The decrease was attributable to reductions in compensation expense and legal expenses offset by an increase in development costs
8-K
EX-99.1
d9uhdo7oj9p6iy5ie
7 Nov 23
Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9:23am
8-K
EX-99.1
kumbbdy mj
8 Aug 23
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
9:05am
8-K
EX-99.1
rat2o
9 May 23
Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:30am
DEFA14A
fowav3r61wr40qgher0
19 May 21
Additional proxy soliciting materials
9:27am
DEFA14A
u0k5n4erw6yk
6 Apr 21
Additional proxy soliciting materials
4:57pm